Abbott India Ltd (ABBOTINDIA):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Abbott India Ltd (ABBOTINDIA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10109
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Abbott India Ltd (Abbott India), a subsidiary of Abbott Laboratories discovers, develops, manufactures and markets branded generic pharmaceuticals, diagnostics tools, medical devices and nutritionals. Its product portfolio encompasses multi-specialty drugs, vitamins and a comprehensive range of products for the treatment of hypothyroidism, vertigo, epilepsy, depression and migraine. The company’s offerings also include vaccines for influenza, typhoid and diarrhea. Abbott India develops pharmaceuticals in various formulations including tablets, liquids, injectables, ointments, granules, powder and capsules. Its product range helps treat gynecological, gastroenterological, urological and neurological diseases, diabetes, pain and infection. Abbott India is headquartered in Mumbai, Maharashtra, India.

Abbott India Ltd (ABBOTINDIA) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Abbott India Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Abbott India Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Abbott India Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Abbott India Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Abbott India Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Abbott India Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Abbott India Enters Into Joint Venture Agreement With Syngene International 10
Licensing Agreements 11
Abbott India Enters into Licensing Agreement with Bharat Biotech 11
Asset Transactions 12
Corona Remedies Acquires Obimet and Thyrocab from Abbott 12
Abbott India May Sell Low-End Brands 13
Abbott India Ltd – Key Competitors 14
Abbott India Ltd – Key Employees 15
Abbott India Ltd – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 17
Corporate Communications 17
Jun 01, 2018: Abbott Names Jawed Zia As Additional Director 17
Mar 27, 2018: Abbott Announces Board Changes 18
Aug 08, 2017: Abbott: Appointment of Mr Rajiv Sonalker as an Additional and Whole-time Director 19
Aug 08, 2017: Abbott: Resignation of Mr Sachin Dharap as the Director of Company 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Abbott India Ltd, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Abbott India Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Abbott India Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Abbott India Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Abbott India Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Abbott India Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Abbott India Enters Into Joint Venture Agreement With Syngene International 10
Abbott India Enters into Licensing Agreement with Bharat Biotech 11
Corona Remedies Acquires Obimet and Thyrocab from Abbott 12
Abbott India May Sell Low-End Brands 13
Abbott India Ltd, Key Competitors 14
Abbott India Ltd, Key Employees 15
Abbott India Ltd, Other Locations 16

List of Figures
Abbott India Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Abbott India Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Abbott India Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Abbott India Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Abbott India Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Abbott India Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Abbott India Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Abbott India Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Abbott India Ltd (ABBOTINDIA):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Allahabad Bank (ALBK)
    Allahabad Bank (ALBK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • Iwatani Corp (8088):企業の財務・戦略的SWOT分析
    Iwatani Corp (8088) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • MMRGlobal Inc (MMRF)-医療機器分野:企業M&A・提携分析
    Summary MMRGlobal Inc (MMRGlobal), formerly MMR Information Systems, Inc., is a personal health records company, which provides Personal Health Record (PHR) products and electronic safe deposit box storage solutions. It offers a wide range of secure, online products that helps consumers and professi …
  • Corindus Vascular Robotics Inc (CVRS):医療機器:M&Aディール及び事業提携情報
    Summary Corindus Vascular Robotics Inc (Corindus) is a medical device company that designs, manufactures and commercializes remote robotic systems for interventional surgical procedures. The company offers next-generation CorPath GRX system, a robotic platform that enables improvements in procedural …
  • Avarga Ltd:企業の戦略・SWOT・財務情報
    Avarga Ltd - Strategy, SWOT and Corporate Finance Report Summary Avarga Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Companhia Energetica de Minas Gerais SA:発電所・企業SWOT分析
    Companhia Energetica de Minas Gerais SA - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, informat …
  • Granite REIT (GRT.UN):企業の財務・戦略的SWOT分析
    Summary Granite REIT (Granite), formerly Granite Real Estate Inc is a construction company that offers real estate investment services. The company acquires, develops, constructs and manages industrial properties. It offers services such as site development, re-zoning to specific uses, assisting wit …
  • Helmerich & Payne Inc (HP):企業の財務・戦略的SWOT分析
    Helmerich & Payne Inc (HP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • iTeos Therapeutics SA:製薬・医療:M&Aディール及び事業提携情報
    Summary iTeos Therapeutics SA (iTeos) is a biotechnology company that develops novel cancer immunotherapies. The company’s pipeline products include small molecule immunomodulators targeting IDO1, A2A, immune check points, STING agonist, and antibodies directed to TIGIT and Galectin 3. It also devel …
  • Insperity Inc (NSP)
    Insperity Inc (NSP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • Purdue Pharma LP:企業の戦略的SWOT分析
    Purdue Pharma LP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Orsted AS Oil & Gas Exploration and Production Operations and Cost Analysis – Q3, 2017
    Orsted AS Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2017 Summary Orsted AS (Orsted) formerly Dong Energy A/S, is an integrated energy company that procures, produces, distributes and trades energy and energy related products. It generates electricity and heat using conv …
  • Pulse Seismic Inc (PSD):企業の財務・戦略的SWOT分析
    Summary Pulse Seismic Inc (Pulse), formerly Pulse Data Inc is a provider of seismic data library for oil and gas exploration. The company acquires, markets and licenses 2D and 3D seismic data to the western Canadian energy sector. It offers services such as project cost tracking, scouting, geophysic …
  • Oglethorpe Power Corporation:企業の戦略・SWOT・財務分析
    Oglethorpe Power Corporation - Strategy, SWOT and Corporate Finance Report Summary Oglethorpe Power Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Safety-Kleen, Inc.:企業の戦略・SWOT・財務分析
    Safety-Kleen, Inc. - Strategy, SWOT and Corporate Finance Report Summary Safety-Kleen, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • EnergySolutions, LLC:電力:M&Aディール及び事業提携情報
    Summary EnergySolutions, LLC (EnergySolutions) is a nuclear services company. It provides a full range of decommissioning and decontamination services to shut down nuclear power plants. The company offers services for the decommissioning and remediation of nuclear sites and facilities, management of …
  • Atrion Corp (ATRI):企業の財務・戦略的SWOT分析
    Summary Atrion Corp (Atrion) is a medical device company that develops, manufactures and supplies surgical equipment and components. The company offers cardiovascular products, fluid delivery products and ophthalmology products. Its products comprise cardiac surgery vacuum relief valves, silicon ves …
  • WidePoint Corp (WYY):企業の財務・戦略的SWOT分析
    Summary WidePoint Corp (WidePoint) operates as a technology company that provides telecommunications lifecycle management, managed mobility, and cybersecurity solutions. The company offers solutions such as telecom expense management, identity management solutions, mobile security solutions, cyberse …
  • OBI Pharma Inc (4174):製薬・医療:M&Aディール及び事業提携情報
    Summary OBI Pharma Inc (OBI Pharma) is a biopharmaceutical company that develops therapies for the treatment of cancer and infectious diseases. The company’s products include adagloxad simolenin, an active immunotherapy which is intended for the treatment of metastatic breast cancer; and OBI-833, a …
  • Parker-Hannifin Corporation:企業の戦略・SWOT・財務分析
    Parker-Hannifin Corporation - Strategy, SWOT and Corporate Finance Report Summary Parker-Hannifin Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆